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In developing organs, the regulation of cell proliferation and cell cycle exit is coordinated. How this coordination is achieved, however, is not
clear. We show that the cyclin kinase inhibitor p57 regulates cell cycle exit of progenitors during the early stages of pancreas formation. In the
absence of p57, the number of cycling progenitors increases, although expansion of progenitor population is prevented by apoptosis. We report
that p57 is a direct target of transcriptional repression by Notch effector, Hes1. Inactivation of Hes1 results in the upregulation of p57 expression in
progenitors, leading to cell cycle arrest, precocious differentiation and depletion of the progenitor pool. We present evidence that in p57/Hes1
double null embryos, the absence of apoptosis results in the expansion of the progenitor population. We propose that Hes1 and p57 not only
coordinate cell cycle exit and self-renewal of pancreatic progenitors during an early stage in organogenesis to regulate the number of pancreatic
progenitors, but could also constitute a surveillance system to eliminate cells with aberrant cell cycle characteristics.
© 2006 Elsevier Inc. All rights reserved.Keywords: Cell cycle; Pancreas; Notch; Organogenesis; Diabetes; Cancer; Proliferation; ApoptosisIntroduction
During organogenesis, proliferation of progenitor cells is
coordinated with differentiation to ensure the correct size, shape
and cellular make-up of the organ. The balance between self-
renewal and programmed withdrawal of cells from the cell cycle
is not only critical for the formation of appropriate number and
types of differentiated cells, but also to prevent cells from
acquiring aberrant proliferative characteristics that can lead to
the initiation of cancer. The mechanisms that balance
proliferation and cell cycle exit as well as perceive aberrant
cell cycle behaviors are not yet well understood. During the
formation of the pancreas, endocrine cell types are generated in
a spatial temporally regulated fashion and direct lineage tracing
analyses indicate that a population of progenitor cells persists to
allow the differentiation of new endocrine cells throughout⁎ Corresponding authors.
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development of the pancreas serves as a good model to study
the molecular basis of how progenitor self-renewal and cell
cycle exit are coordinated during organogenesis.
The pancreas originates during embryogenesis as evagina-
tions from the posterior foregut endoderm to form epithelial
buds (reviewed in Edlund, 1999; Hebrok et al., 2000; Wells and
Melton, 1999). These epithelial buds consists of cells that
express the homeogene, Pdx1 (Ahlgren et al., 1996; Offield et
al., 1996). Direct lineage tracing using the Cre/LoxP method
demonstrated that the Pdx1-expressing cells are multipotent
pancreatic progenitor cells and give rise to all mature pancreatic
cell types (Gannon et al., 2000; Gu et al., 2003; Herrera et al.,
2002). Several studies suggest that cell–cell signaling involving
the canonical Notch pathway plays a crucial role in maintaining
a population of progenitor cells. Targeted disruption of Notch
ligand Delta-like 1(Dll1), intracellular mediators RBP-JK, or
Hes1 resulted in precocious differentiation that led to a
depletion of progenitor cells (Apelqvist et al., 1999; Jensen et
al., 2000). The similarity in the phenotypes of mice genetically
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that canonical Notch signaling acting via Hes1 regulates
progenitor self-renewal in early pancreatic development.
Further support for the role of Notch signaling in regulating
differentiation and self-renewal in the pancreas comes from
gain-of-function experiments in which Notch activation in the
progenitor cells prevented differentiation of endocrine cells
(Hald et al., 2003; Murtaugh et al., 2003). These results suggest
that Notch-mediated signaling blocks the differentiation of
pancreatic progenitor cells and instead forces the cell to remain
in an undifferentiated state.
The decision to differentiate is made at the G1-phase where D-
type cyclins and cyclin kinase inhibitors (CKIs) play an
important role in regulating cell cycle exit. CKIs regulate cell
cycle progression by blocking phosphorylation of the retino-
blastoma protein. Two groups of CKIs have been described
(reviewed in Sherr and Roberts, 1999). These include the Ink4
family members that specifically inhibit cyclin D-Cdk4/6
activity, and the CIP/KIP family that includes p21Cip1,
p27Kip1, and p57Kip2, which exhibit promiscuous CDK-
inhibitory activity. How does the G1 cell cycle machinery
interact with the Notch pathway to block differentiation and
promote self-renewal?We show that p57mediates cell cycle exit
of pancreatic progenitors and is a target of transcriptional
repression byHes1. Inactivation of Hes1 led to increased number
of progenitors expressing p57 that precociously exited the cell
cycle. This prompted us to ask whether the absence of p57would
rescue the defects in the self-renewal of the progenitors in Hes1
mutants. We show that in p57/Hes1 double null embryos, self-
renewal of pancreatic progenitors was rescued and led to an
expansion of the pancreatic bud. These observations support a
proposal that Hes1 and p57 coordinate the binary decision choice
of pancreatic progenitor to either exit the cell cycle or self-renew.Materials and methods
Animal husbandry and embryo dissection
Targeted disruption of the p57Kip2 and Hes1 alleles has been described
previously (Zhang et al., 1997; Ishibashi et al., 1995). To ensure the maternal
inheritance of the disrupted p57 allele, all matings were between a male
p57Kip2+/+ and p57Kip2+/− females in a C57BL/6 background. Embryos were
isolated from these mice and considered to be 0.5 days of gestation at noon of
the day the plugs were detected. Embryos were dissected in cold PBS, fixed in
4% formaldehyde for 45 min to 3 h, depending on the age of the embryo,
followed by dehydration in ethanol and stored at −20°C until processed for
paraffin embedding. Genomic DNAwas extracted from the excess tissue using
the DNeasy kit (Qiagen). Genotyping was performed as previously described
(Caspary et al., 1999; Ohtsuka et al., 1999). Genotyping was also confirmed
by performing immunohistochemistry (as described below) for p57Kip2.
Immunohistochemistry
The gastrointestinal tracts were oriented during the embedding process in
paraffin so that sections were cut along the anterior–posterior axis. Five-
micrometer sections were deparaffinized in toluene, rehydrated in grades of
alcohol and washed in H2O. All slides were subject to antigen retrieval
protocols using Antigen Unmasking Buffer (Vector Labs). After antigen
unmasking, the slides were cooled to room temperature. All slides werepermeabilized in 0.2% Triton X-100/TBS for 20 min, and non-specific binding
of antibodies blocked with 0.2%Tween 20/3% IgG-free BSA/TBS. Primary
antibodies were diluted in the blocking solution at the following dilutions:
mouse anti-Glucagon 1:1000 (Sigma); rabbit anti-Glucagon 1:500 (Immunos-
tar); guinea pig anti-insulin 1:500 (Dako); goat anti-p57 1:200 (clone M-20,
Santa Cruz); rabbit anti-cleaved caspase-3 1:200 (Cell Signaling); mouse anti-
Isl1 (39.4D5)1:50 (Developmental Studies Hybridoma Bank); rabbit anti-Hes1
1:100 (gift of T. Sudo); rabbit anti-phospho-histone H3 1:200 (Upstate);
mouse anti-Pdx1 1:500 (a gift from J. Habener); rabbit anti Ngn3 1:200 (gift
of M. Sander). Donkey- and goat-derived secondary antibodies conjugated to
FITC, Cy3 or AMCA were diluted 1:500 (Jackson Laboratories). All slides
were mounted with Vectashield with or without DAPI (Vector Labs). Slides
were viewed using a Leica DM6000 microscope and images acquired using
Openlab software.
BrdU injections, proliferative index and cell quantification
BrdU (25 μg per g of body weight) was injected intraperitoneally into
pregnant dams 30 min (or otherwise stated) before harvesting the embryos.
Mouse anti-BrdU antibody (1:100) (Amersham/Pharmacia) and the Pdx1
antibody were diluted in the nuclease buffer provided with the BrdU antibody.
For calculation of the proliferative index, the number of Pdx1-positive cells and
Pdx1- or BrdU-positive cells in the dorsal pancreatic buds were counted and the
percentage of BrdU incorporation calculated (proliferative index). For cell
quantification, four sections (3 sections apart) from each of three p57+/−m
pancreas and three wild-type littermates were analyzed in this manner, giving a
total of 24 data points. Quantification of progenitor population was carried out
using three embryos from each genotype. Sections were stained for Pdx1 and
Isl1 and five sections from each embryo were used to calculate the number of
Pdx1+ and Isl1+ cells. The relative percentage of each population was calculated
(for example, Pdx1+/Pdx1+ + Isl1+ × 100). Statistical significance was
determined using Student's t test.
RNA isolation, RT-PCR and reporter gene assay
The pancreas were dissected in cold PBS and homogenized in TRI Reagent
(Molecular Research Center) and total RNA prepared according to the
manufacturer's methods (Chomczynski and Sacchi, 1987). RT-PCR was
performed as described previously (Bhushan et al., 1998). cDNAwas synthesized
from RNA using a standard reverse transcription reaction. cDNA was amplified
using PCR Mastermix (Qiagen) and the following thermal cycler protocol: 94°
denaturation for 2 min, 35 cycles of 55° annealing for 1:30, 72° extension for
1 min, 93° denaturation for 1 min and a final extension at 72° for 5 min. Primers
used were p27Kip1: forward—cgactttcagaatcataagc, reverse—cttaattcggagctgtttac;
p57Kip2: forward—atctgacctcagacccaat, reverse—gccgttagcctctaaacta; p21Cip1:
forward—ggaactttgacttcgtcac, reverse—ctttaagtttggagactgg.
Cos7 cells were cultured in DMEM supplemented with 10% fetal bovine
serum (FBS) and antibiotics. The transfections were performed using
Lipofactamine 2000 (Invitrogen) according to manufacture's instruction. CAT
assay was carried out 24 h after the transfection using CAT ELISA kit (Roche).
The level of the expression of CATwas normalized to beta-galactosidase activity
expressed from a co-transfected vector.
Results
p57 is expressed in pancreatic progenitor cells that have exited
the cell cycle
As Cip/Kip cell cycle regulators play an important role in
coordinating cell cycle exit with terminal differentiation
(reviewed in, Casaccia-Bonnefil and Liu, 2003), we analyzed
which Cip/Kip family members were expressed in the early
developing pancreas. RT-PCR on the pancreatic region of the
developing gut showed that p57 was strongly expressed at the
early stages of pancreatic bud formation (Fig. 1A). We
Fig. 1. p57 is expressed in pancreatic progenitor cells that have exited the cell cycle. RT-PCR expression analysis of Cip/Kip family in the pancreatic region of the
developing embryo: p57 was the predominant Cip/Kip family member expressed in the pancreatic bud (A). By immunofluorescence analysis, p57 was found to be
expressed in the pancreatic epithelium for a short duration during early pancreatic development. At E10.5, p57 was expressed in a subset of Pdx1+ epithelial progenitor
cells (B). A subset of epithelial progenitors continued to express p57 at E11.5 and strong expression was also observed in the pancreatic mesenchyme (C). By E12.5,
very few epithelial progenitors expressed p57, although expression was still observed in the pancreatic mesenchyme (D). p57 was not expressed in cells that
incorporated BrdU at E11.5 (E) p57 was not co-expressed with transcription factors that mark early differentiated endocrine cells at E11.5. p57 expression does not
overlap with Ngn3 (F) or Isl1 (G).
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immunohistochemistry during embryogenesis. The expression
of p57 was detected at embryonic day (E) 10.5, and co-staining
with Pdx1 revealed that p57 expression was restricted to a
subset of progenitor cells within the epithelial bud (Fig. 1B). At
E11.5, p57 expression continued to be detected in a subset of
progenitor cells (Fig. 1C) and strong expression was also
detected in mesenchymal cells surrounding the epithelial bud.
Expression of p57 at this stage was also detected in the
progenitor cells of the ventral pancreatic buds (not shown). By
E12.5, however, few pancreatic epithelial cells that expressed
p57 were detected, although strong expression of p57 persisted
in the pancreatic mesenchyme (Fig. 1D). p57 expression was
not detected in the pancreatic epithelium at later stages of
embryogenesis, indicating that p57 expression in pancreatic
progenitors was limited to a short period of pancreatic
organogenesis.
Next we examined the expression of p57 in progenitor cells
in relation to cell cycle progression. Pregnant dams were
injected with bromodeoxyuridine (BrdU) and embryos were
analyzed for the expression of p57. No overlap of p57
expression was observed with BrdU after 1/2-hour pulse,
which indicated that p57-expressing cells were not in S-phase
(Fig. 1E). To correlate the expression of p57 with the generation
of differentiated postmitotic cells during the formation of the
pancreas, we stained the pancreatic bud with p57 and Ngn3 or
Isl1, transcription factors that are early markers for endocrineprecursor cells. (Ahlgren et al., 1997; Gradwohl et al., 2000).
The majority of p57-expressing cells did not overlap with Ngn3
or Isl1 (Figs. 1F and G). These expression analyses indicated
that p57 could mediate cell cycle exit of pancreatic progenitors
but did not appear to play a role in differentiated endocrine cells.
Pancreatic progenitor cells reenter the cell cycle in the absence
of p57
We reasoned that if p57 played a role in mediating cell cycle
exit of pancreatic progenitors, the loss of p57 would lead to an
increase the number of cycling progenitors. To test this, we
analyzed whether the proliferation of pancreatic progenitor cells
was affected in mice in which the p57 gene had been inactivated
by homologous recombination in ES cells (Zhang et al., 1997).
p57 is imprinted such that only the maternal allele is active;
therefore, offspring that inherit the inactivated allele of p57
from p57+/− females are designated p57+/−m and are null for p57
expression. To determine if the proportion of cycling pancreatic
progenitor cells changed due to the absence of p57, embryos
were pulse labeled with BrdU to mark cells in S-phase, then
stained with Pdx1 and BrdU. In E11.5 wild-type embryos,
around 25% of the pancreatic progenitor cells were in S-phase
and tended to reside in the peripheral layer of the epithelial bud
(Fig. 2A). The proportion of progenitor cells in S-phase was
significantly increased in the pancreatic bud of p57+/−m
littermate embryos (Fig. 2B). Quantification of S-phase index
Fig. 2. Increased cycling progenitors at the expense of endocrine differentiation in p57+/−m pancreatic bud. The number of pancreatic progenitors that incorporate BrdU
in wild-type embryos (A) was increased in p57+/−m littermates (B). Quantification of the proliferation index showed that at E11.5, more progenitor cells incorporated
BrdU in p57+/−m pancreas (35.4 ± 0.4) compared to wild-type littermates (22.9 ± 0.5) P < 0.001 (C). However, by E12.5, the numbers of progenitors incorporating
BrdU were similar in p57+/−m (28.2 ± 1.2) and wild-type littermates (31.0 ± 2.4) P > 0.5. The number of Pdx1-positive cells and Pdx1- or BrdU-positive cells in the
dorsal pancreatic buds were counted and the percentage of BrdU incorporation calculated (proliferative index). For cell quantification, four sections (3 sections apart)
from each of three p57+/−m pancreas and three wild-type littermates were analyzed in this manner, giving a total of 24 data points. Statistical significance was
determined using Student's t test.
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progenitor cells in the pancreatic epithelium from p57 null
embryos were in S-phase entry compared to wild-type
littermates; 22.9 ± 0.5 (WT) versus 35.4 ± 0.4 (p57+/−m),
P < 0.001 (Fig. 2C). This increased percentage of S-phase
progenitor cells corresponded roughly to the percentage of
progenitor cells that would have expressed p57 at this stage in
development (Fig. 1B). However, one day later at E12.5, when
p57 expression is barely detectable in the pancreatic epithelium
but expressed strongly in the mesenchyme, the proportion of S-
phase cells in the pancreas from p57+/−m and wild-type
littermates embryos were similar 28.2 ± 1.2 (WT) versus
31.0 ± 2.4 (p57+/−m) P > 0.5 (Fig. 2C). Thus, the loss of
mesenchymal p57 expression did not appear to have any affect
on the cell cycle characteristics of pancreatic progenitors. This
suggests that p57-mediated cell cycle exit of pancreatic
progenitors was not likely to be due to indirect effects of the
mesenchyme on the pancreatic epithelium.
Reentry of progenitors into the cell cycle was compensated by
apoptosis in p57+/−m embryos
The increased proliferation of pancreatic progenitor cells in
p57+/−m embryos did not result in any obvious increase in the
size of the pancreatic epithelium, which lead us to question
whether these progenitor cells underwent apoptosis. The
expression of activated caspase-3 was used as an indicator for
initiation of apoptosis (reviewed in Nicholson, 1999).
Apoptotic nuclei were rarely observed in the pancreatic
epithelium from wild-type embryos at E10.5 (Fig. 3A). By
contrast, widespread apoptosis was observed in the pancreatic
epithelium in the p57+/−m littermate embryos (Fig. 3B). These
cells had typical apoptotic morphology and were apoptotic by
other assays such as TUNEL (data not shown). The activatedcaspase-3 staining within the epithelial bud did not overlap
with Isl1, which indicated that the apoptosis observed in the
pancreas was limited to progenitor cells, not derived from
postmitotic endocrine cells. Apoptosis was also observed
within the pancreatic epithelium of p57+/−m embryos at E11.5
(Figs. 3C and D) but very few apoptotic cells were observed
within the pancreatic epithelium of p57+/−m embryos at E12.5
(not shown) consistent with the fact that p57 expression in
pancreatic epithelium declines by E12.5. These results suggest
that in the absence of p57, cell cycle reentry of progenitor
cells that would otherwise have exited the cell cycle lead to
apoptosis.
Hes1 suppresses p57 expression
Increased progenitor self-renewal at the expense of differ-
entiation in p57+/−m developing pancreas was opposite of the
phenotype observed in Hes1−/− embryos, in which precocious
differentiation occurred at the expense of pancreatic progenitor
self-renewal (Apelqvist et al., 1999; Jensen et al., 2000). We
reasoned that precocious differentiation of pancreatic progenitor
cells in mice that lack the Hes1 would have been preceded by
cell cycle arrest. Therefore, we investigated if Hes1 interacted
with p57 to regulate the balance of proliferation and cell cycle
exit of pancreatic progenitors. To investigate whether p57-
mediated cell cycle exit could be responsible for the precocious
differentiation observed in Hes1−/− pancreas, we compared the
expression of p57 in pancreatic progenitor cells in Hes1−/− and
wild-type littermates. Because precocious differentiation
resulted in depletion of pancreatic progenitors by E10.5, we
analyzed the expression of p57 at an earlier time point when
Pdx1-expressing progenitor cells were still present in the
pancreatic epithelium of Hes1−/− embryos. Pdx1-expressing
cells outline the developing dorsal bud at E9.5 in wild-type (Fig.
Fig. 3. Widespread apoptosis within the p57+/−m pancreatic epithelium. Using
an antibody against the cleaved (activated) form of caspase-3, a marker for
programmed cell death, very little apoptosis was observed in the wild-type
pancreas at E10.5 (A). Widespread apoptotic cells were seen within the
epithelial buds derived from p57+/−m littermates (B). Co-staining with Isl1
showed that pancreatic progenitors rather than differentiated endocrine cells
underwent apoptosis. Co-staining of beta-catenin with the cleaved form of
caspase-3 outlined the epithelial bud. Very few apoptotic cells were seen within
the E11.5 pancreatic bud (C), although apoptotic cells were clearly seen within
the epithelial bud of p57+/−m littermates (D).
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revealed that, at this stage, very few Pdx1-expressing cells also
express p57 in wild-type embryos (4.03 ± 2.09%) (Figs. 4B and
C). By contrast, p57 was dramatically upregulated in the dorsal
bud of Hes1−/− embryos (Fig. 4E) and most Pdx1-expressing
cells within the dorsal bud also expressed p57 (74.01 ± 4.82%)
(Fig. 4G). p57 expression was also observed in the progenitor
cells of the ventral bud of Hes1−/− embryos (not shown). These
results suggested that in the absence ofHes1, increased numbers
of progenitors expressed p57 and shifted the progenitor fate to
differentiation, thereby resulting in the depletion of progenitor
cells.
The increased number of progenitors that expressed p57 in
Hes1−/− pancreas led us to compare the expression pattern of
Hes1 and p57 in the pancreatic bud of WT mice.
Immunofluorescence analysis showed that p57 and Hes1
were expressed in distinct cells within the E10.5 pancreatic
bud (Figs. 4H–J). p57-expressing cells were often adjacent to
Hes1-expressing cells, but cells that expressed both Hes1 and
p57 were not detected. The expression of Hes1 and p57 in
distinct cells is likely to be a general phenomenon as Hes1
and p57 are also expressed in distinct cells in the neural tube
(data not shown). To gain further insights into how p57 could
interact with Hes1 in regulating cell cycle exit of pancreatic
progenitors, we isolated the 7-kb sequence 5′ of the first exon
of mouse p57. This 7-kb sequence contained two elements, E-I (214 bp) and E-II (199 bp) that are conserved in the human
gene, suggesting that these elements could be involved in the
regulation of p57 expression. These two elements were
utilized in a yeast one hybrid screen to identify if Herp/Hes
family of transcriptional repressors interacted with the E-box
CACCTG in E-I (P. Zhang, unpublished data). To test
whether Hes1 could directly control the transcription of p57,
we utilized a plasmid construct, p57-CAT, in which the 7-kb
mouse p57 promoter region was used to drive CAT
(chlorophenicol acetyltransferase) reporter expression (Fig.
4K). Because the yeast hybrid screen suggested that the E-1
element of the p57 promoter region was responsible for the
interaction with Hes1, we also constructed a plasmid p57ΔE-I-
CAT, in which the E-I region was deleted (Fig. 4K). These
CAT constructs were transfected to Cos7 cells alone or
together with Hes1 expression vectors. The CAT assay result
(Fig. 4L) showed that co-transfection of Hes1 led to
suppression of CAT expression. Furthermore, the suppression
of CAT was dependent on the E-I interacting region as co-
transfection of Hes1 with p57ΔE-I-CAT failed to suppress
CAT expression. Together, these results indicate that Hes1 can
directly interact with the p57 promoter and control prolifer-
ation through transcriptional repression of p57.
Rescue of pancreatic progenitors in p57/Hes1 double null
embryos
Our results suggest that in Hes1−/− embryos, the
upregulation of p57 in pancreatic progenitors resulted in
cell cycle arrest of progenitor cells that led to the depletion of
the progenitor population. As p57+/−m embryos showed the
opposite phenotype, we investigated whether the loss of p57
in the Hes1−/− embryos could rescue the proliferation of
pancreatic progenitors. To test this, we generated p57/Hes1
double null embryos. Based on mendelian ratios, fewer than
expected p57/Hes1 double null embryos were recovered at
E11.5 and no double null embryos were recovered at later
stages indicating embryonic lethality after E11.5. We analyzed
the pancreas from E11.5 embryos by immunofluorescence
staining for Pdx1 and glucagon to assess the pancreatic
progenitor population and endocrine differentiation. As
expected, the depletion of the progenitors at the expense of
endocrine differentiation was clearly evident in the pancreatic
region of the Hes1−/− embryos (Fig. 5B) compared to wild-
type (Fig. 5A) and p57+/−m littermates (Fig. 5C). Significant-
ly, however, a large number of pancreatic progenitors
expressing Pdx1 were clearly seen in the pancreatic region
of p57/Hes1 double null embryos (Fig. 5D). The majority of
the Pdx1-expressing progenitors of p57/Hes1 double null
embryos did not express Ngn3 indicating that these cells had
not committed to an endocrine fate (data not shown). The
pancreatic bud shown in Fig. 5D was representative of the
expansion of Pdx1+ cells seen in the double mutant embryos
and quantification of the total number of Pdx1+ cells from 5
sections per embryo from a total of three embryos per
genotype confirmed that progenitor population was indeed
expanded in p57/Hes1 double null embryos compared to
Fig. 4. p57 expression is suppressed by Hes1. (A–C)Wild-type embryos. At E9.5, Pdx1 expression marks the developing pancreatic bud (A). Very few cells within the
p pancreatic bud (outlined) express p57 at this stage (B). Merged image showing p57-expressing epithelial cells co-express Pdx1 (C). (D–F) Hes1−/− littermate
embryos. At E9.5, Pdx1-expressing progenitor cells are still present in the pancreatic bud, although depleted by E10.5 (D). In contrast to wild-type littermates, almost
all the epithelial cells within the pancreatic bud (outlined) express p57 in Hes1−/− embryos (E). Merged images shows that these p57-expressing cells within the
pancreatic bud co-express Pdx1 (F). Percentage of p57-expressing Pdx1+ cells in is greatly increased in Hes1−/− embryos when compared to WT littermates (n = 3)
(74.01 ± 4.82% versus 4.03 ± 2.09%), P < 0.001 (G). Localization of p57 (H) and Hes1 (I) within the E10.5 pancreatic bud show that show that p57 and Hes1 are
expressed in distinct cells (J). Constructs generated from the 7-kb mouse p57 promoter region used to drive CAT (chlorophenicol acetyltransferase) reporter expression
included the two conserved elements E-I and E-II (K). Transfection of the CAT constructs into CV-1 cells together with Hes1 expression vector resulted in suppressed
CAT expression that is E-I dependent (L).
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progenitor cells to differentiated endocrine cells, we calculat-
ed the relative percentage of Isl1+ cells and Pdx1+ cells to the
total Isl1+ + Pdx1+ cells. Such analysis illustrated the near
depletion of the progenitor population due to endocrine
differentiation in Hes1−/− embryos and showed that loss ofboth p57 and Hes1 restored the balance of differentiation and
progenitor population (Fig. 5F).
The expansion of the pancreatic bud led us to evaluate
whether apoptosis of pancreatic progenitors was prevented in
p57/Hes1 double null embryos. We co-stained for the
expression of glucagon to allow easy identification of the
Fig. 5. Rescue of pancreatic progenitor pool in p57/Hes1 double null embryos. To analyze the progenitor cell population, we stained the pancreatic region of E11.5
embryos for Pdx1 and glucagon (A). The depletion of the progenitors was evident in the pancreatic region of the Hes1−/− littermates (B). No increase in the progenitor
cell population was evident in p57+/−m embryos (C); however, a dramatic expansion of the pancreatic progenitor population was evident in the p57/Hes1 double null
embryos (D). Quantification of the number of Pdx1+ cells (5 section from 3 embryos of each genotype) showed expansion of the progenitor population in the p57/Hes1
double null embryos (E). The proportion of Isl1+ and Pdx1+ cells in the pancreatic epithelium in the different genotypes as indicated and expressed as relative
percentage of total Isl1+ and Pdx1+ cells. The depletion of progenitor cells in the Hes1−/− pancreatic epithelium due to precocious differentiation and rescue of the
progenitor population in p57/Hes1 double null embryos are evident (F).
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observed within the pancreatic buds derived from either wild-
type (Fig. 6A) or Hes1 homozygous littermates embryos (Fig.
6B) but was widespread in the pancreatic epithelium of p57+/−m
embryos (Fig. 6C). Strikingly, the p57/Hes1 double null
embryos showed little evidence of apoptotic cells in the
pancreatic epithelium (Fig. 6D). The absence of activated
caspase-3 staining was not due to depletion of pancreatic
epithelial cells, as nuclei staining showed a number of
undifferentiated cells were present in the pancreatic bud (Fig.
6F). These results indicated that Hes1 was involved in
triggering the apoptosis of pancreatic progenitor cells in the
p57+/−m embryos.
Discussion
During the early steps in the formation of the pancreas, the
expansion of Pdx1-expressing multipotent progenitor popula-
tion is coordinated with the differentiation of endocrine cells.
Several studies have shown that Notch signaling via Hes1 plays
a crucial patterning role in the development of the pancreas by
selecting progenitor cells to either differentiate or self-renew
(Apelqvist et al., 1999; Jensen et al., 2000; Murtaugh et al.,
2003), although the mechanism by which Notch signalingregulates this binary decision process is unknown. Here we
show that a mediator of cell cycle exit, p57, is a target of
transcriptional repression by Hes1, a downstream target of
Notch signaling and a known transcriptional repressor that has
been shown to prevent differentiation by suppressing the
expression of differentiation factors such as Ngn3 (Lee et al.,
2001). Thus, Hes1 activation in pancreatic progenitors can
suppress the expression of both Ngn3 and p57 to simultaneously
prevent cell cycle exit and differentiation. Other studies indicate
Hes type bHLH protein, deadpan has been shown to regulate
dacapo, a CKI with homology to vertebrate p27 during the
formation of optic lobes in Drosophila (Wallace et al., 2000). In
addition, a recent study showed that Hes1 was also capable of
suppressing the expression of p27 (Murata et al., 2005).
Another study on oligodendrocyte specification in zebrafish
showed that the p57 homolog is negatively regulated by Notch
signaling (Park et al., 2005). Thus, the regulation of CKIs by the
Hes family may be a conserved mechanism utilized to control
proliferation during development.
We show that p57 is present during the early stages of
pancreatic development (E10.5–E12.5) that correspond to
massive expansion of the Pdx1-expresing progenitors. It is
notable that p57 is not present during secondary transition
(E13.5–E15.5) when the majority of endocrine cell differenQ
Fig. 6. Pancreatic progenitors in p57/Hes1 double null embryos do not undergo apoptosis. We generated p57/Hes1 double null embryos and analyzed pancreatic
progenitors for apoptosis at E11.5 by immunofluorescence staining of activated caspase-3 and co-stained for the expression of glucagon that allowed easy
identification of the pancreatic region. Apoptotic pancreatic progenitors were rarely observed within the pancreatic buds derived from either wild-type (A) orHes1 null
littermates embryos (B) but widespread in the pancreatic epithelium of p57+/−m embryos (C). There was no evidence of apoptotic cells in the pancreatic epithelium of
p57/Hes1 double null embryos (D). (E, F) DAPI staining of the sections shown in panels C and D, respectively. The lack of apoptotic cells in panel D is not due to
depletion of cells in the epithelial bud of p57/Hes1 double null embryos (F).
29S. Georgia et al. / Developmental Biology 298 (2006) 22–31tiation occurs, suggesting that other G1 regulators are likely to
be involved in regulating endocrine cell differentiation. Our
results indicate the primary role of p57 during embryogenesis is
to coordinate with Hes1 the balance between proliferation and
cell cycle exit to regulate the number of pancreatic progenitors.
The proliferation of multipotent progenitor cells must be
precisely regulated as the different endocrine and exocrine
cells types emerge at different times during development. For
example, if progenitor cells exited the cell cycle too early, cell
types that differentiate later in development will be reduced in
the mature organ. Thus, properly controlled terminal cell cycle
exit accompanied by differentiation early in organogenesis has
repercussions for the size and the cellular make-up of the mature
pancreas.
It is possible that suppression of p57 in progenitor cells
allows them to respond to an extrinsic mitotic signal. We have
previously shown that FGF10 is a mitotic signal expressed in
the mesenchyme at E9.5–E11.5, the same time in organogenesis
as the expression of p57 in epithelial progenitor cells (Bhushan
et al., 2001). We propose that progenitors that express Hes1 and
suppress the expression of p57 would respond to the extrinsic
mitogen, FGF10, whereas progenitors that express p57 would
disregard the FGF10 signal and exit the cell cycle. In support of
this scenario, the activation of Notch targets by ectopic FGF10
expression as well as the requirements of the Notch signaling
for the proliferative effects of FGF10 has been recently been
shown (Hart et al., 2003; Miralles et al., 2006; Norgaard et al.,
2003). It is worth pointing out that although Hes1 is the major
effector of the Notch pathway, Notch signaling on occasion canbe effected by Hes1-independent events (reviewed in Louvi and
Artavanis-Tsakonas, 2006). Furthermore, Hes1 expression
alone does not mimic all of Notch's diverse effects on cells
(Matsuno et al., 1997; Shawber et al., 1996). However, the
similarities in the phenotypes of mice genetically altered at the
level of ligand or downstream effectors indicated that Notch
signaling acts via Hes1 during early pancreatic development
(Apelqvist et al., 1999; Jensen et al., 2000).
The reentry of pancreatic progenitors into the cell cycle, due
to the absence of p57, is accompanied by widespread apoptosis.
A similar phenomenon where inappropriately cycling cells are
removed during organogenesis has been reported during retinal
development. In retinal progenitors, p57 mediates cell cycle
arrest and in p57-deficient retina, inappropriate S-phase reentry
was quickly followed by apoptosis (Dyer and Cepko, 2000).
Similarly, conditional deletions of Rb in the retina also result in
inappropriate cell cycle activity and apoptosis (MacPherson et
al., 2003, 2004). The results presented here indicate that Hes1,
presumably acting downstream of Notch signaling, is required
for the apoptosis of progenitors in the p57-deficient pancreas.
As Hes1 and p57 are expressed in distinct progenitor cells in the
pancreatic epithelium, non-cell autonomous mechanisms may
be involved in the initiation of apoptosis in progenitors. Notch
signaling is involved in establishing differences between
adjacent cells and accumulating evidence indicates that
reciprocal signaling involving feedback regulation amplifies
and consolidates the differences between adjacent progenitors
(Artavanis-Tsakonas et al., 1999). The cellular and develop-
mental context of these adjacent progenitor cells dictates the
30 S. Georgia et al. / Developmental Biology 298 (2006) 22–31response to the reciprocal Notch signaling. We suggest that the
cell cycle state is an important component of the cellular context
of the progenitor cells perceived by Notch signaling. In this
scenario, Notch signals to affect specific cell fate in a context-
specific manner and inappropriately cycling cells that normally
would have undergone cell cycle arrest instead undergo
apoptosis. In an alternative scenario, it is possible that Hes1-
expressing progenitors form a microenvironment from which
survival factors are secreted. For example, Notch activation in
the Drosophila wing can activate Wnt, a secreted morphogen
and survival factor (Diaz-Benjumea and Cohen, 1995).
Uncontrolled proliferation of the progenitor cells due to the
disruption of the coordination of self-renewal and differentia-
tion could potentially set the stage for tumor formation.
Increasing evidence is accumulating to support the hypothesis
that disruption of Notch signaling and its downstream targets
may play a role in certain cancers (Maillard and Pear, 2003).
Notch downregulation appears to be critical during tumor
progression in small cell lung cancer and in HPV-related
cervical cancer (Talora et al., 2002). Furthermore, Notch acts as
a tumor suppressor in the skin, as conditional inactivation of
Notch1 in basal epidermal layers leads to spontaneous skin
cancer (Nicolas et al., 2003). Elimination of inappropriately
cycling cells may serve as a tumor suppressor function and the
coordination between Hes1 and CKIs could be involved in
perceiving and eliminating cells that have aberrant cell cycle
states. Moreover, these findings may also be useful in the
successful development of methods for ex vivo manipulation of
pancreatic precursor cell proliferation and differentiation for
therapeutic approaches to treat diabetes.
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